Results 321 to 330 of about 375,497 (354)
Some of the next articles are maybe not open access.
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside.
Seminars in Cancer Biology, 2019Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway is one of the major cellular signaling pathways play an important role in basic intracellular functions.
A. Alzahrani
semanticscholar +1 more source
Biomaterials, 2019
Osteoarthritis (OA) is the most common disabling joint disease throughout the world and its therapeutic effect is still not satisfactory in clinic nowadays.
Jiangyi Wu +13 more
semanticscholar +1 more source
Osteoarthritis (OA) is the most common disabling joint disease throughout the world and its therapeutic effect is still not satisfactory in clinic nowadays.
Jiangyi Wu +13 more
semanticscholar +1 more source
Seminars in Cancer Biology, 2019
The phosphatidylinositol 3-kinase (PI3K)-Akt and the mammalian target of rapamycin (mTOR) represent two vital intracellular signaling pathways, which are associated with various aspects of cellular functions.
Devesh Tewari +4 more
semanticscholar +1 more source
The phosphatidylinositol 3-kinase (PI3K)-Akt and the mammalian target of rapamycin (mTOR) represent two vital intracellular signaling pathways, which are associated with various aspects of cellular functions.
Devesh Tewari +4 more
semanticscholar +1 more source
Current Opinion in Pharmacology, 2005
mTOR kinase plays a central role in the activation of many cell types, and blocking mTOR function with rapamycin results in arrest of the cell cycle at the G1 phase. Recently, several additional molecules have been identified in the mTOR pathway, providing further opportunities to interfere with cell activation and develop novel therapeutic agents ...
Deborah A, Young +1 more
openaire +2 more sources
mTOR kinase plays a central role in the activation of many cell types, and blocking mTOR function with rapamycin results in arrest of the cell cycle at the G1 phase. Recently, several additional molecules have been identified in the mTOR pathway, providing further opportunities to interfere with cell activation and develop novel therapeutic agents ...
Deborah A, Young +1 more
openaire +2 more sources
mTOR Pathway and mTOR Inhibitors in Cancer Therapy
20101. N. Kubica and J. Blenis "mTORC1: A signaling integration node involved in cell growth" 2. Z. Feng and A.J. Levine "The Regulation of the IGF-1/mTOR Pathway by the p53 Tumor Suppressor Gene Functions" 3. H. Mead, M. Zeremski and M. Guba "mTOR Signaling in Angiogenesis" 4. J. Brugaroles "mTOR signaling and hypoxia" 5. D. Akhavan and P.S. Mischel "mTOR
openaire +1 more source
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
Science, 2005Dos D. Sarbassov +3 more
semanticscholar +1 more source
2012
The senescence program is activated in response to diverse stress stimuli potentially compromising genetic stability and leads to an irreversible cell cycle arrest. The mTOR pathway plays a crucial role in the regulation of cell metabolism and cellular growth.
openaire +2 more sources
The senescence program is activated in response to diverse stress stimuli potentially compromising genetic stability and leads to an irreversible cell cycle arrest. The mTOR pathway plays a crucial role in the regulation of cell metabolism and cellular growth.
openaire +2 more sources
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Nature Cell Biology, 2002K. Inoki +4 more
semanticscholar +1 more source

